Old CIC Events
24/02/2022
Transient JAK/STAT pathway inhibition prevents B-ALL development in genetically predisposed mice
Ana Casado García — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca
18/02/2022
Novel therapeutic strategies against cancer metastasis: From Research to Innovation
Angélica Figueroa — Instituto de Investigación Biomédica A Coruña (INIBIC)
03/02/2022
Epigenetic control of tissue plasticity in pancreatic regeneration and tumorigenesis.
Direna Alonso Curbelo — IRB, Barcelona
27/01/2022
Understanding early lymphoma formation from a single-cell epigenomics and 3D chromatin perspective
Renée Beekman — Center for Genomic Regulation (CRG)
25/01/2022
USAL Program Medical Immunology 2022 (1st Edition)
Prof. Jacques J.M van Dongen — Centro de Investigación del Cáncer-Instituto de Biología Celular y Molecular del Cáncer y Leiden University Medical Center.
20/01/2022
A truncating variant of RAD51B associated with primary ovarian insufficiency provides insights into its meiotic and somatic functions
Yazmine Bejarano — Centro de Investigación del Cáncer
13/01/2022
PCNA- deubiquitinating enzymes associate with Replication Forks to ensure a precise progression through S-phase
Javier Zamarreño — Centro de Investigación del Cáncer, (CIC, IBMCC), Salamanca
16/12/2021
Mechanisms of gene regulation after fertilization: from transcription to decay
Antonio Giráldez — Yale University School of Medicine.
09/12/2021
Protein bombs and liquid adhesions in immune cell mediated killing in cancer and infection
Michael Dustin — University of Oxford
02/12/2021
Illuminating the beginning of life
Melina Schuh — Max Planck Institute for Biophysical Chemistry, Göttingen Germany
26/11/2021
Defensa de tesis: Cáncer de mama HER2+: mecanismos de resistencia a tratamientos dirigidos y nuevas dianas terapéuticas.
Lucía Gandullo Sánchez — Centro de Investigación del Cáncer
25/11/2021
Intracellular traffic of LAT and its role in T cell activation
Claire Hivroz — Institut Curie, [Paris, France]